Tag: radiotherapy
-
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer — NEJM
Among patients with stage T1b, T1c, T2a, or T2b prostate adenocarcinoma and a PSA level of 20 ng per milliliter or less, the use of short-term ADT for 4 months before and during radiotherapy was associated with significantly decreased disease-specific mortality and increased overall survival. According to post hoc risk analysis, the benefit was mainly…